Leidos director gains shares via dividend equivalents

Leidos Holdings director Harry M. Jansen Kraemer Jr. received 363.5515 shares of common stock as a grant credited through dividend equivalent rights to a Key Executive Stock Deferral Plan.

Rhea-AI Filing Summary

Leidos Holdings director Harry M. Jansen Kraemer Jr. received 363.5515 shares of common stock as a grant credited through dividend equivalent rights to a Key Executive Stock Deferral Plan. Following this award, he holds 129,174.6938 shares indirectly through the plan and 93,281 shares directly. This is a routine compensation-related acquisition, not an open-market trade.

Insights

Insider transactions analyst

Routine compensation-related share accrual via dividend equivalents.

The filing shows director Harry M. Jansen Kraemer Jr. acquired 363.5515 Leidos common shares through dividend equivalent rights in a Key Executive Stock Deferral Plan. These are compensation-linked credits, not open-market purchases, and carry weak signaling value about his short-term view.

After the transaction, he holds 129,174.6938 shares indirectly via the plan and 93,281 shares directly. No derivatives remain listed, and there are no sales or option exercises, indicating a modest, routine increase in his equity-based compensation exposure rather than an active trading decision.

Insider Trade Summary

Grant/Award: 363.5515 shares

Grant/Award 2 txns

Insider KRAEMER HARRY M JANSEN JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	363.5515	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 129,174.6938 shares (Indirect, By Key Executive Stock Deferral Plan); Common Stock — 93,281 shares (Direct)

Footnotes (1)

1. F1. Dividend equivalent rights.

Key Figures

Shares granted: 363.5515 shares Indirect holdings after transaction: 129,174.6938 shares Direct holdings after transaction: 93,281 shares

3 metrics

Shares granted 363.5515 shares Dividend equivalent rights credited to Key Executive Stock Deferral Plan

Indirect holdings after transaction 129,174.6938 shares Common Stock held through Key Executive Stock Deferral Plan

Direct holdings after transaction 93,281 shares Common Stock held directly

Key Terms

Dividend equivalent rights, Key Executive Stock Deferral Plan, indirect ownership, Form 4

4 terms

Dividend equivalent rights financial

"Dividend equivalent rights."

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Key Executive Stock Deferral Plan financial

"By Key Executive Stock Deferral Plan"

indirect ownership financial

"ownership_type": "indirect"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Leidos (LDOS) director Harry Kraemer report in this Form 4?

He reported receiving 363.5515 Leidos common shares as a compensation-related grant. The award came through dividend equivalent rights credited to a Key Executive Stock Deferral Plan, increasing his indirect holdings without any open-market buying or selling activity disclosed in this filing.

Is the Leidos (LDOS) Form 4 for Harry Kraemer an insider buy or a market trade?

The Form 4 reflects a grant or award, not a market trade. Shares were acquired via dividend equivalent rights in a Key Executive Stock Deferral Plan, so this is routine compensation rather than an open-market purchase or sale that might signal an active trading decision.

How many Leidos (LDOS) shares does Harry Kraemer hold after this Form 4?

After the reported transactions, he holds 129,174.6938 Leidos common shares indirectly through a Key Executive Stock Deferral Plan and 93,281 shares directly. These figures highlight his substantial ongoing equity exposure as a director, combining both deferred compensation and directly held stock.

What are dividend equivalent rights mentioned in the Leidos (LDOS) Form 4?

Dividend equivalent rights are compensation features that credit additional units or shares based on dividends paid on underlying stock. In this case, they resulted in 363.5515 additional Leidos shares being credited to a Key Executive Stock Deferral Plan account for director Harry Kraemer.

Does the Leidos (LDOS) Form 4 show any insider selling by Harry Kraemer?

No insider selling is reported in this Form 4. The filing only shows an acquisition of 363.5515 shares via dividend equivalent rights and updated direct and indirect holdings, indicating a small, routine increase in his equity-based compensation, not a disposition of shares.

How significant is the Leidos (LDOS) Form 4 transaction for shareholders?

The transaction is relatively minor and compensation-related. It involves a small grant of 363.5515 shares to an existing large holding, with no open-market trades. Such routine equity accruals typically have limited impact on overall share supply or on an investor’s broader thesis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRAEMER HARRY M JANSEN JR

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		363.5515(1)	A	$0	129,174.6938	I	By Key Executive Stock Deferral Plan
Common Stock								93,281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Dividend equivalent rights.

Remarks:

	/s/ Ramune M. Kligys by PoA of Harry M. Jansen Kraemer, Jr.	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)